Related Experiment Video
Updated: Aug 30, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Cell surface receptors activate p21-activated kinase 1 via multiple Ras and PI3-kinase-dependent pathways
Raymond E Menard1, Raymond R Mattingly
1Department of Pharmacology, Wayne State University, 540 E. Canfield, Room 6326, Detroit, MI 48201, USA.
Abstract:
p21-activated kinases (PAKs) were the first identified mammalian members of a growing family of Ste20-like serine-threonine protein kinases. In this study, we show that PAK1 can be stimulated by carbachol, lysophosphatidic acid (LPA), epidermal growth factor (EGF), and phorbol 12-myristate 13-acetate (PMA) by multiple independent and overlapping pathways. Dominant-negative Ras, Rac, and Cdc42 inhibited PAK1 activation by all of these agonists, while active Rac1 and Cdc42 were sufficient to maximally activate PAK1 in the absence of any treatment. Active Ras induced only a weak activation of PAK1 that could be potentiated by muscarinic receptor stimulation. Studies using inhibitors of the EGF receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI3-kinase) and protein kinase C (PKC) revealed that all of the cell surface agonists could activate PAK1 through pathways independent of PKC, that EGF stimulated a PI3-kinase dependent pathway to stimulate PAK1, and that muscarinic receptor stimulation of PAK1 was predominantly mediated through this EGF-R-dependent mechanism. Activation of PAK1 by LPA was independent of PI3-kinase and the EGF receptor, but was inhibited by dominant-negative RhoA. These results identify multiple Ras-dependent pathways to activation of PAK1.
Insights
p21-activated kinases (PAKs) are crucial serine-threonine protein kinases. This study reveals multiple pathways, including Ras-dependent ones, activate PAK1 using various agonists like LPA and EGF.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- p21-activated kinases (PAKs) are mammalian Ste20-like serine-threonine protein kinases.
- PAK1 is implicated in various cellular processes, but its activation mechanisms are complex.
Purpose of the Study:
- To elucidate the diverse signaling pathways that regulate PAK1 activation.
- To investigate the roles of small GTPases (Ras, Rac, Cdc42, RhoA) and upstream kinases in PAK1 stimulation.
Main Methods:
- Stimulation of PAK1 using agonists: carbachol, lysophosphatidic acid (LPA), epidermal growth factor (EGF), and phorbol 12-myristate 13-acetate (PMA).
- Utilized dominant-negative and active forms of Ras, Rac, and Cdc42 to assess their roles in PAK1 activation.
- Employed inhibitors for EGF receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI3-kinase), and protein kinase C (PKC).
Main Results:
- PAK1 activation by all tested agonists was inhibited by dominant-negative Ras, Rac, and Cdc42.
- Active Rac1 and Cdc42 independently induced maximal PAK1 activation.
- EGF-induced PAK1 activation involved PI3-kinase, while muscarinic receptor stimulation was EGF-R-dependent.
- LPA-mediated PAK1 activation was independent of PI3-kinase and EGF receptor but sensitive to RhoA inhibition.
- Multiple Ras-dependent pathways contribute to PAK1 activation.
Conclusions:
- PAK1 activation is orchestrated by multiple, converging, and diverging signaling pathways.
- Small GTPases Rac and Cdc42 play critical roles in PAK1 activation.
- Specific agonists utilize distinct upstream signaling cascades to modulate PAK1 activity.
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
